Kentucky Sen. Paul Failed to Disclose Wife’s Stock Trade
Kentucky Sen. Rand Paul waited more than a year to disclose that his wife purchased stock in a company that makes a COVID-19 treatment, an investment made after Congress was briefed on the threat of the virus but before the public was largely aware of its danger. The Republican filed a mandatory disclosure Wednesday revealing on Feb. 26, 2020 that Kelley Paul purchased somewhere between $1,001 and $15,000 worth of stock in Gilead, which makes the antiviral drug remdesivir. Under a 2012 law called the Stock Act, which was enacted to stop lawmakers from trading on insider information, anymore
Leave a comment